Article

Nitrofurantoin Induced Reversible Interstitial Lung Disease

1★, 2★ Corresponding author

  1. 1Department of Clinical Pharmacy, Aster Mims Hospital, Kannur, Kerala, INDIA..
  2. 2Department of Critical Care Medicine, Aster Mims Hospital, Kannur, Kerala, INDIA..

CORRESPONDENCE

Shabana Ashraf

Department of Clinical Pharmacy, Aster Mims Hospital, Kannur, Kerala, INDIA..

shabana.ashraf63@gmail.com

Received: 04-05-2023; Revised: 30-06-2023; Accepted: 11-07-2023.

Volume 16, Issue 4 · pp. 366–368 · 2023 · DOI: 10.5530/ijopp.16.4.63

View on IJOPP original site ↗

ABSTRACT

Drug-induced interstitial lung disease is an increasingly common cause of morbidity and mortality. Nitrofurantoin is a broad-spectrum antibiotic used for acute uncomplicated or simple cystitis as well as for prophylaxis of recurrent infection. We recently encountered a case of Nitrofurantoin-induced interstitial lung disease in an elderly patient who was on Nitrofurantoin for a year and a half for recurrent urinary tract infections. On further evaluation, she was diagnosed with drug-induced interstitial lung disease, which was confirmed by radiographic evidence. Nitrofurantoin was discontinued and managed with low-dose systemic glucocorticoids. This case report highlights the need for close vigilance of pulmonary toxicities in patients taking long-term Nitrofurantoin therapy.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Ashraf, S., & Salahudheen, S. (2023). Nitrofurantoin Induced Reversible Interstitial Lung Disease. Indian Journal of Pharmacy Practice, 16(4), 366–368. https://doi.org/10.5530/ijopp.16.4.63